NEXENTIS TECHNOLOGIES INC. Short-term Debt
NEXENTIS TECHNOLOGIES INC. (NXTS) had Short-term Debt of $215.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:ShortTermBorrowings · last filed 2026-08-13
- 2026-06-30: Short-term Debt $215.00K.
- 2026-03-31: Short-term Debt $364.00K.
- 2025-12-31: Short-term Debt $740.00K.
- 2025-09-30: Short-term Debt $1.11M.
| Period end | Short-term Debt |
|---|---|
| 2026-06-30 | $215.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $364.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $740.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.11M 10-Q · filed 2025-11-13 |
| 2024-06-30 | $1.20M 10-Q · filed 2024-08-14 |
| 2022-09-30 | $1.86K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.75K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $6.20K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $8.39K 10-K · filed 2023-03-27 |
| 2021-09-30 | $8.05K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $7.93K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $7.71K 10-Q · filed 2021-05-18 |
| 2020-12-31 | $7.95K 10-K · filed 2022-03-31 |
| 2020-09-30 | $7.38K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $7.29K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $7.05K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $7.23K 10-K · filed 2021-03-29 |
| 2018-12-31 | $23.14K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |